Delivery Order SPE2DB22D9309-SPE2DB24FAE88

Award Date 5/10/24
Potential Completion Date 6/3/24
Potential Value $7.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product, at a ceiling value of $15,761.76. The delivery order has a firm fixed price pricing structure and runs through June 11, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC)...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency's Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $7,880.88 contract is for the delivery of EYLEA 2 MG/0.05 ML VIAL 0.05ML pharmaceutical products to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,880.88 contract is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a specialized pharmaceutical product. The delivery order was issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which covers a wide range of branded and generic...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,880.88 award is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a medication used to treat certain eye conditions. The delivery order is part of a larger indefinite delivery contract (IDC) with the DLA valued at up to $499,999,999, which allows the DLA to issue firm fixed-price...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $16,338.24, is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML to the DLA. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which runs through December 31, 2025. The IDC allows the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML. The contract has a ceiling value of $7,880.88 and an ultimate completion date of September 4, 2024. The delivery order is part of a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $2,626.96, is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, valued at up to $499,999,999 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of EYLEA 2 MG/0.05 ML syringes with a total ceiling value of $5,167.72. It is a firm fixed-price contract with a performance period ending on September 10, 2024. The contract is issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of the pharmaceutical product EYLEA 2 MG/0.05 ML VIAL 0.05ML. The single-award contract has a firm fixed price and a ceiling value of $6,567.40. It is not associated with any set-aside designation. The contract is part of a larger indefinite delivery contract, SPE2DB, held by DMS Pharmaceutical Group with DLA. That contract, valued up to...
This is a delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The contract is for the delivery of EYLEA 2 MG/0.05 ML SYRINGE 0.05ML, a pharmaceutical product, with a ceiling value of $38,757.90 and a period of performance through August 2, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS...
  • SPE2DB22D9309
    Indefinite Delivery Contract
  • SPE2DB22D9309-SPE2DB24FAE88
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product, with a ceiling value of $7,880.88. The contract has a firm fixed-price pricing type and an ultimate completion date of June 3, 2024. This order is placed under a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation.

Generated 8/9/24, 9:38 AM